Transforming Health Care with David Rick...

<p>Seattle Storm Forward Nneka Ogwumike has already built her legacy as a WNBA Champion with the Los Angeles Sparks in 2016. The MVP of league (also 2016). The first overall pick in 2012, and before that she brought Stanford to the Final Four, four years in a row. Now after the p ... Show More

<p>Throughout his 10-year NFL career, Brandon Copeland had a side hustle: teaching financial skills to college students at the Wharton School of Business at the University of Pennsylvania. Known by his teammates as “the money professor,” he opens up his playbook on how to win the ... Show More

<p>After graduating from college, Tiffany James was struggling to pay off student loan debt when a colleague suggested she try her hand at investing. She dove in and learned the basics, figured out a formula that worked and made millions. Now she’s teaching others to do the same ... Show More

<p>Nicolai Tangen meets with David Ricks, CEO of&nbsp;Eli&nbsp;Lilly, for a discussion about the pharmaceutical giant's remarkable journey. At the forefront is&nbsp;Eli&nbsp;Lilly's breakthrough work with weight reduction drugs, which are showing promise far beyond their original ... Show More

Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see ... Show More

<p>(0:00) Introducing Eli Lilly CEO Dave Ricks</p> <p>(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China</p> <p>(7:08) GLP-1 pricing and capital allocation after a breakout pharma product</p> <p>(12:56) Why Biotech VC has plummeted, " ... Show More

Eli Lilly CEO Dave Ricks says the company is working on expanding its medicine supply as the global obesity rate increases. Speaking with Bloomberg's Caroline Hyde at the Economic Club of New York, the head of the pharma giant says that they are looking to create an oral tablet i ... Show More

Amid the uncertainty surrounding the coronavirus pandemic, Goldman Sachs’ global medical director Dr. Michael Rendel joins by phone to talk about what employees can do to stay healthy and productive while working remotely – from setting up comfortable work stations to taking time ... Show More

We've curated a special 10-minute version of the podcast for those in a hurry.   Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/eli-lilly-ceo-the-weight-loss-drug-revolution-ai-in/id1614211565?i=1000693848152&l=nb Nicolai Tangen meets with David Ri ... Show More

Andrew Kitchner is the Founder and CEO of New Wave Solutions, an extraordinary firm with an extraordinary leader, specializing in helping organizations retain top-tier talent. On this edition of This Is DesignIntelligence, he shares the workplace habits and expectations that have ... Show More

Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen’s next shot at an Alzheimer’s treatment. - Why companies can’t “muscle their way” i ... Show More

Kate Davis talks with Dr. David Rock about what makes for meaningful work. David is the Co-Founder & CEO of NeuroLeadership Institute, a cognitive science consultancy that has advised some of the biggest companies. He is also the author of four books including Your Brain at Work.